Table 3.
Utility of HTS-TCR in skin: key points.
| T-cell clonality tests are now an essential component of the diagnostic toolkit for CTCL |
| Immunosequencing precisely identifies and quantifies the genetic sequence of TCR CDR3 of malignant clones |
| Increased sensitivity and specificity of HTS-TCR compared to PCR aids in diagnosis of early-stage MF |
| HTS-TCR can provide TCF, a measure that has prognostic value |
| HTS-TCR can be used to monitor the treatment response by tracking malignant T-cell clones in the skin and blood after treatment |
| HTS-TCR can help distinguish between disease recurrence, treatment related cutaneous adverse events, and co-existing malignancies |